Search - tctmd.com

Displaying 81 - 100 of 100

Sort: Relevancy | Date

Presentation

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

Presenter: Francesco Liistro

February 24, 2014

Presentation TCT 2013

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

Presenter: Kenneth Rosenfield

October 30, 2013

Presentation TCT 2013

TCT-132. Prospective, Multicenter Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular SystemTM

Presenter: Koen Deloose

October 28, 2013

Presentation TCT 2013

The Global Effect of Zilver PTX on Management of Femoropopliteal Disease

Presenter: Michael Dake

October 27, 2013

Presentation TCT 2013

Update on Percutaneous Femoropopliteal Bypass: The Next Evolutionary Step in SFA Treatment?

Presenter: James Joye

October 27, 2013

Presentation Scripps 2013

Optimal Treatment of the Femoropopliteal Segment: Tips, Tricks and Device Selection

Presenter: John R. Laird

October 03, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Presenter: Antonio Micari

April 03, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

Presentation

A Meta-analysis of Endovascular vs. Surgical Reconstruction of Femoropopliteal Arterial Disease

Presenter: George A. Antoniou

December 10, 2012

Presentation

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

Presenter: Michael Werk

December 06, 2012

Presentation TCT 2012

Femoropopliteal Atherectomy: A Critical Appraisal

Presenter: Lawrence Garcia

October 24, 2012

Presentation TCT 2012

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Presenter: Dierk Scheinert

October 23, 2012

Presentation TCT 2012

Tips and Tricks for Successful Crossing of Femoropopliteal CTOs

Presenter: Andrej Schmidt

October 23, 2012

Presentation TCT 2012

STOP-IC: A Prospective, Randomized Trial of Cilostazol after Endovascular Treatment of Femoropopliteal Lesions

Presenter: Hiroyoshi Yokoi

October 22, 2012

Presentation

Endovascular Brachytherapy Using Liquid Beta-Emitting Rhenium-188 (Re-188) for the Treatment of Long-Segment Femoropopliteal In-Stent Stenosis

Presenter: Martin Werner

August 31, 2012

Presentation

Paclitaxel-Coated vs. Uncoated Balloon Angioplasty Reduces TLR in Femoropopliteal Disease

Presenter: S. Cassese

August 06, 2012

Presentation TCTAP 2012

Drug-Eluting Balloon or Stent In Femoropopliteal Lesions: How Far Are We?

Presenter: Mark W. Burket

April 25, 2012

Presentation

Clinical Evaluation of a Paclitaxel-Eluting Balloon for Treatment of Femoropopliteal Arterial Disease

Presenter: Antonio Micari

March 22, 2012

Presentation TCT 2012

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Presenter: Michael Werk, Thomas Albrecht, Dirk R. Meyer, Heiner Stiepani, Beatrix Schnorr, Enrique Lopez H?nninen

January 03, 2012

Advertisement

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

TCT-132. Prospective, Multicenter Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular SystemTM

The Global Effect of Zilver PTX on Management of Femoropopliteal Disease

Update on Percutaneous Femoropopliteal Bypass: The Next Evolutionary Step in SFA Treatment?

Optimal Treatment of the Femoropopliteal Segment: Tips, Tricks and Device Selection

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

A Meta-analysis of Endovascular vs. Surgical Reconstruction of Femoropopliteal Arterial Disease

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

Femoropopliteal Atherectomy: A Critical Appraisal

TCT-585: Six-Month Results of the BIOLUX P-I First-in-Man Study Comparing a Paclitaxel-Releasing Balloon Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Tips and Tricks for Successful Crossing of Femoropopliteal CTOs

STOP-IC: A Prospective, Randomized Trial of Cilostazol after Endovascular Treatment of Femoropopliteal Lesions

Endovascular Brachytherapy Using Liquid Beta-Emitting Rhenium-188 (Re-188) for the Treatment of Long-Segment Femoropopliteal In-Stent Stenosis

Paclitaxel-Coated vs. Uncoated Balloon Angioplasty Reduces TLR in Femoropopliteal Disease

Drug-Eluting Balloon or Stent In Femoropopliteal Lesions: How Far Are We?

Clinical Evaluation of a Paclitaxel-Eluting Balloon for Treatment of Femoropopliteal Arterial Disease

The Pacifier Trial. A Randomized Multicenter Trial Evaluating Prevention of Restenosis with Paclitaxel-Coated PTA Balloon Catheters in Stenosis or Occlusion of Femoropopliteal...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content